A novel yeast-based screening system for potential compounds that can alleviate human α-synuclein toxicity.
Anyaporn SangkaewThanaporn KojornnaRyoya TanahashiHiroshi TakagiChulee YompakdeePublished in: Journal of applied microbiology (2021)
Yeast-based assay system can be used to discover novel neuroprotective drug candidates which may be either efficiently suppress-α-syn aggregation or enhance ubiquitin-dependent degradation.